LATEST ALERTS
UK medical bodies leave CBD out of their discussions on cannabis
21st May 2019 - News analysis |
More and more British organisations are starting to develop a policy towards medical cannabis, but CBD guidelines appear to be lagging behind
Health and science
US veterans at odds with federal agency over legalising clinical trials
8th May 2019 - News analysis |
The US Department of Veterans Affairs has opposed three CBD-related bills in Congress, leading some to wonder if the agency is looking to punish veterans who admit using medical cannabis
CBD is a feminist issue too as women take a progressive leading role
1st May 2019 - News analysis |
Women are emerging as key players in the movement to promote medical CBD: starting their own businesses, campaigning for legalisation and creating networks for future empowerment
Will FDA draw a line between other CBD products and pharmaceuticals?
29th April 2019 - News analysis |
The US FDA is to hold a public hearing on 31st May on the safety of products containing cannabis or cannabis-derived compounds ― and stakeholders will be looking for a dividing line
When will CBD foods be legal in the US? Don’t hold your breath
25th April 2019 - News analysis |
Could CBD soon be legally sold as a dietary supplement or food in the US? The answer depends on how quickly the federal regulatory framework on cannabis in general and CBD in particular can be eased
Hemp growing on the rise, but Ireland still sends abroad for medical supplies
25th April 2019 - News analysis |
Ireland’s Department of Health still won’t commit to allowing farmers to grow cannabis for medical use, two years after the health minister announced a medical cannabis access programme
Child health association ‘an obstacle to cannabis prescriptions,’ claims UK MP
24th April 2019 - News analysis |
A UK member of parliament has accused the president of a child healthcare organisation of lying to the parliamentary health and social care committee and dismissing the concerns of families
Big Pharma ‘must not be allowed to set EU legal agenda on medical cannabis’
17th April 2019 - News analysis |
Europe desperately needs harmonised legislation on medical cannabis – but it could take five years, and Big Pharma must not be allowed to set the agenda, delegates at a conference in Brussels heard
Questions in UK parliament after medical cannabis is seized at airport
9th April 2019 - News analysis |
Just two out of around 80 people prescribed medical cannabis in the UK have received products containing THC, with the rest getting CBD, the British parliament has heard
UK government loses a pro-cannabis minister as Brine exits over Brexit
3rd April 2019 - News analysis |
UK member of parliament Steve Brine, a supporter of medical cannabis, has resigned as under-secretary of state for public health over Brexit-related issues
Mainstream US drugstore chains announce plans to sell CBD
29th March 2019 - News analysis |
CBD products appears to be entering the mainstream of US retail. One of the largest retail pharmacy chains in the US, CVS is already selling a range of products in at least eight US states and Walgreens has announced plans to sell the product in nine states.
Philippines moves one step closer to legalising medical cannabis
29th March 2019 - News analysis |
The Philippines moved one step closer to legalising cannabis for medical use when a bill was approved on its final reading, but its progress to law could be scuppered by opposition from president Rodrigo Duterte.
Cannabis troubles – UK committee hears of inconsistency and confusion
26th March 2019 - News analysis |
Inconsistent quality of products purchased online, and confusion over cannabis itself, could be putting patients at risk, a group of UK MPs were told during presentations on medical cannabis and related issues
Berkeley team hold out hope for cannabinoids synthesised from yeast
14th March 2019 - News analysis |
Obscure cannabinoids and even completely new ones could be produced synthetically from yeast, along with THC and CBD, according to scientists at the University of California in Berkeley
Big dollars are undeterred by red tape tangle and inconsistent enforcement
11th March 2019 - News analysis |
North American businesses are still investing millions in the CBD hemp market, despite the uncertainty generated by new legislation and clampdowns on retailers, with many US and Canadian firms acquiring nascent businesses
CBD to treat concussion disorders? Retired NHL players join study
8th March 2019 - News analysis |
A charity for retired ice hockey players is teaming up with one of the world’s biggest cannabis companies and a medical research body to research how CBD treatment impacts concussion-related disorders
French CBD users warned against buying from illicit online suppliers
7th March 2019 - News analysis |
The French Medicines Agency (Agence Nationale du Médicament, ANSM) has issued a warning to consumers against buying illicit CBD products online
GW Pharmaceuticals reports loss despite success of CBD-based drug
1st March 2019 - News analysis |
CBD drug manufacturer GW Pharmaceuticals saw a significant net loss in the last quarter, despite growth and sales of its cannabis-derived pharmaceutical drugs going to plan
CBD in foods: UK FSA set to issue guidance
1st March 2019 - News analysis |
The UK Food Standards Agency (FSA) will issue further guidance next week on the use of cannabinoids as novel food ingredients
FDA sets the date for hearing on legalising hemp-derived CBD
1st March 2019 - News analysis |
The US Food and Drug Administration (FDA) has set a tentative date of sometime in April for a long-awaited public meeting to hear from stakeholders and begin a rulemaking process on legalising hemp-derived CBD, according to FDA Commissioner Scott Gottlieb
Global CBD rules will get tougher, then normalise, expert predicts
20th February 2019 - News analysis |
Regulations governing hemp-derived CBD are likely to increase sharply in the near future but then tail off as the product is integrated into general regulatory frameworks for food, cosmetics and industrial products, according to a legal expert
Science review sees promise and problems in medical use of CBD
19th February 2019 - News analysis |
CBD shows promise for treating some medical conditions but the potential for interactions with other drugs is a cause for concern, as is poor quality control, according to a recent review of science in the field
Israel can grow its cannabis and CBD sector with government blessing
7th February 2019 - News analysis |
Although cannabis is considered a dangerous drug in Israel, government support for cannabis start-ups and liberal policies on research have helped the country develop an active medical cannabis industry
Argentina – land of opportunity beset by confusion and doubt
29th January 2019 - News analysis |
A growing domestic CBD consumer base and excellent potential for cannabis farming make Argentina an intriguing market despite regulatory ambiguity and differences in opinion between national and provincial authorities
US veterans urge CBD legalisation in Georgia, Tennessee drafts CBD bills
28th January 2019 - News analysis |
Congressional politicians in Tennessee have been turning their attention to possible regulation of farming for CBD, while those in Georgia have been addressed by military veterans eager for CBD to be legalised
CBD classed as pharmaceutical product: Taiwan regulatory report
24th January 2019 - Regulatory reports |
In our report looking at the regulations governing CBD in Taiwan, we find that CBD is a classified as a pharmaceutical product and the growing of cannabis plants for any purposes, and the addition of CBD to cosmetic products, is prohibited
LloydsPharmacy may be path to stronger CBD for UK supermarkets
21st January 2019 - News analysis |
Though Lloyds is a lesser name than Boots among UK pharmacy chains, its partnership with Sainsbury’s means it could be poised to dramatically expand the range of the supermarket’s CBD product offerings.
LloydsPharmacy started stocking a range of CBD products in October last year.
The shape of things to come: what 2019 will bring for CBD
31st December 2018 - News analysis |
While CBD has been one of THE stories of 2018, the novelty phase is now over, and 2019 will be the year the longer-term future of CBD products becomes clearer. CBD-Intel looks at prospects for the months ahead
We still regulate foods and health claims, FDA reminds US CBD industry
23rd December 2018 - News analysis |
Removing hemp from the federal narcotics Schedule 1 list does not mean that all CBD products are now permitted, the US Food and Drug Administration (FDA) has warned
CBD could hinder potential of cannabis to treat glaucoma, study warns
20th December 2018 - News analysis |
The presence of CBD could render cannabis useless as a treatment for glaucoma, new research warns. Long-term use of the substance may even worsen one of the main risk factors for the eye disease
Epidiolex for Europe may come from UK-grown cannabis
3rd December 2018 - News analysis |
The CBD-based epilepsy drug Epidiolex could become available in Europe, manufactured from cannabis already growing in eastern England
Tests find labels on oil mis-state THC levels – sometimes dangerously
29th November 2018 - News analysis |
Most European CBD oils label their CBD content correctly but comparatively few are accurate about THC, a study in the Czech Republic has found
US federal government soliciting information for CBD research
22nd November 2018 - News analysis |
Securing cannabis supplies for research purposes is the focus of an information request from the US federal government. They are asking businesses about the ability to analyse, produce, and even distribute cannabis products for research. The National Institute on Drug Abuse (NIDA) is probing for businesses that have the “in-house capability to act as a centralized source for acquisition and/or production, analysis, and distribution of cannabis and related materials for research purposes,” according to a federal notice.
CBD treatments on the way as FDA grants 20th ‘orphan drug’ designation
14th November 2018 - News analysis |
The number of cannabidiol-based pharmaceutical products in the pipeline continues to grow, with the US Food and Drug Administration (FDA) recently granting yet another orphan drug designation for CBD
CBD treatments ‘should be available on US health insurance’
5th November 2018 - News analysis |
Dr Sanjay Gupta, president of the American Pain Association (APA), has called on US insurance companies to cover CBD treatments for patients
Don’t judge cannabis by THC/CBD content alone, say scientists
1st November 2018 - News analysis |
Many cannabis strains marketed as distinct are in fact chemically much the same, but there may also be non-obvious differences and their effects on humans should not be judged purely on THC and CBD content, scientists say
Restricted but in demand: France regulatory snapshot
23rd October 2018 - Regulatory reports |
Despite being Europe’s biggest hemp grower and reputedly its highest cannabis user, France has one of Europe’s most restrictive regulatory environments for cannabis use.
FDA will pass on comments about CBD to WHO drug dependency experts
22nd October 2018 - News analysis |
Comments invited by the FDA on the potential abuse and medical usefulness of CBD and other cannabis-derived substances will be submitted to the World Health Organization (WHO)
A new Brazilian president is unlikely to free CBD from its legal chains
17th October 2018 - News analysis |
Prospects for CBD in Brazil depend hugely on the outcome of the forthcoming presidential election, in which the far right-wing candidate Jair Bolsonaro has emerged as a very strong favourite
CBD prescriptions may be just around the corner for UK patients
16th October 2018 - News analysis |
CBD products could be prescribed to British patients from as early as next month after the UK government announced plans to lift restrictions on the medical use of cannabis
Epilepsy research charity warns against unlicensed CBD products
12th September 2018 - News analysis |
A British health charity has warned people with epilepsy against using CBD products that do not have a pharmaceutical licence
‘Cannabis with nicotine affects brain differently than either on its own’
11th September 2018 - News analysis |
Cannabis and nicotine together have notably different effects on the brain than either of them taken on their own. That’s the conclusion of US researchers who noted that cannabis is commonly consumed in conjunction with tobacco
Experiments on mice suggest you can’t get addicted to CBD
23rd August 2018 - News analysis |
A new series of animal studies purports to show that CBD is non-addictive – potentially clearing the way for further research into the mechanisms behind its possible beneficial qualities
French warnings over ‘stores likely to be selling illegal products’
17th August 2018 - News analysis |
Judicial bodies in France have issued statements clarifying the national legal framework for products containing cannabidiol (CBD) and asked local enforcement authorities to ensure compliance with current legislation
Potentially deadly rat poison found in synthetic cannabinoids, says FDA
30th July 2018 - News analysis |
Synthetic cannabinoid products being sold in convenience stores and gas stations across the US are contaminated with an ingredient commonly found in rat poison, the US FDA says
US authorities call into question the legality of CBD
8th June 2018 - News analysis |
US government agencies have questioned the legality of cannabidiol (CBD) – just as the industry is starting to benefit from increased public awareness
CBD ‘may reduce temptation’ for quitters to pick up a cigarette
21st May 2018 - News analysis |
Cannabidiol (CBD) could be helpful in smoking cessation, but the area is little researched and more work is required, says a London scientist who will soon publish a paper on the topic
CBD in Europe: an overview of an emerging vaping market
24th April 2018 - Market reports |
Vaping is reported to be one of the best ways to absorb CBD, a cannabinoid present in cannabis which has relaxing and pain-relieving effects but produces no psychoactive “high”. E-liquid containing CBD is already on the market
French firm aims to roll out its nicotine dosage device in Europe and US
2nd October 2017 - News analysis |
Enovap, an innovative French hardware manufacturer, has announced plans to move into the US market, where it hopes to apply its technology to medicinal cannabis use
